TOG Review (RCOG Journal)
MRCOG Part 2
Subfertility and Reproductive Medicine
Fertility on ice
Key Statistics
- >80% — Overall survival, childhood/adolescent cancer
- 30% / 18% — Male survivors: Azoospermia / oligospermia
- ≥10 Gy — Ovarian irradiation → POI risk
Don't-miss facts
-
Ovarian/testicular tissue cryopreservation are the only FP options for prepubertal patients (girls/boys respectively) – oocyte/embryo freezing needs postpubertal ovarian stimulation
-
Avoid OTC autotransplantation in leukaemia – high risk of reintroducing malignancy via contaminated ovarian tissue
-
Oocyte vitrification reclassified non-experimental by ASRM/ESHRE in 2013; TTC and IVM remain experimental
-
Ovarian irradiation ≥10 Gy → premature ovarian insufficiency; alkylating agents (cyclophosphamide, busulfan, chlorambucil) carry highest gonadotoxic risk
-
Edinburgh criteria for OTC: age <35y, realistic 5-year survival, >50% POI risk, informed consent, negative HIV/syphilis/hepatitis B, not pregnant/no children
-
GnRH agonists during chemo: benefit shown only in adult breast cancer; not recommended in other cancers (draft ESHRE) and ineffective prepubertally
-
Cancer patients undergoing oocyte vitrification have worse outcomes than elective FP patients: live birth 40% vs 70%
-
Survivors are ~38% less likely to achieve pregnancy than the general population – ensure timely fertility counselling
FP options by pubertal status
Prepubertal girl: ovarian tissue cryopreservation, ovarian transposition
Postpubertal girl: oocyte/embryo cryopreservation, OTC, IVM (experimental)
Prepubertal boy: testicular tissue cryopreservation (experimental, no live births) Postpubertal boy: sperm cryopreservation
Abbreviation Key
- FP — fertility preservation
- HSCT — haematopoietic stem cell transplant
- AMH — anti-müllerian hormone
- ICSI — intracytoplasmic sperm injection
- OTC — ovarian tissue cryopreservation
- hCG — human chorionic gonadotrophin
- TTC — testicular tissue cryopreservation
- GV — germinal vesicle (immature oocyte stage)
- IVM — in vitro maturation
- MII — metaphase II (mature oocyte stage)
- OHSS — ovarian hyperstimulation syndrome
- ASRM — American Society of Reproductive Medicine
- POI — premature ovarian insufficiency
- ESHRE — European Society of Human Reproduction and Embryology
- GnRH — gonadotrophin-releasing hormone
- ASCO — American Society of Clinical Oncology
Source: Hartigan L, Glover LE, Wingfield M. Fertility on ice: an overview of fertility preservation for children and adolescents with cancer. The Obstetrician & Gynaecologist 2021;23:170–176. doi:10.1111/tog.12753
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).